FDA issued a Warning Letter to Surmasis Pharmaceutical on 11/6/2018 as a result of this inspection.
FDA investigators audited the Surmasis Pharmaceutical - Des Moines, IA, United States facility and issued inspectional observations (via FDA 483) on 01 Mar 2018.
Add To Cart
- Category: Human Drugs
- Inspection end: 01 Mar 2018
- Location: Des Moines, United States
- FEI: 3011596846